Apyx Medical Corporation
APYX
$3.63
-$0.06-1.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.21M | -14.54M | -17.26M | -20.04M | -23.46M |
| Total Depreciation and Amortization | 655.00K | 576.00K | 556.00K | 580.00K | 599.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.15M | 4.78M | 5.14M | 5.39M | 6.06M |
| Change in Net Operating Assets | -1.59M | 773.00K | 2.26M | 1.66M | -1.25M |
| Cash from Operations | -8.00M | -8.41M | -9.31M | -12.41M | -18.05M |
| Capital Expenditure | -1.11M | -1.08M | -718.00K | -742.00K | -722.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.11M | -1.08M | -718.00K | -742.00K | -722.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.00K | -19.00K | -20.00K | -20.00K | -20.00K |
| Issuance of Common Stock | 9.79M | 7.05M | 7.00M | 7.00M | 7.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -188.00K | -175.00K | -175.00K | -205.00K | -235.00K |
| Cash from Financing | 9.58M | 6.86M | 6.81M | 6.78M | 6.75M |
| Foreign Exchange rate Adjustments | -466.00K | -241.00K | -152.00K | 104.00K | 113.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.00K | -2.88M | -3.38M | -6.27M | -11.91M |